 |
|
|
| |
Lack of Effect of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir
Disoproxil Fumarate on Glomerular Filtration Rate in HIV-Infected Patients
|
| |
| |
Reported by Jules Levin
18th International Workshop on Clinical Pharmacology of Antiviral Therapy, June 14-16, 2017, Chicago, IL
Joseph M. Custodio, Sophia R. Majeed, Hui Wang, Andrew Plummer, Kah Hiing J. Ling, Martin Rhee, Moupali Das, Brian P. Kearney
Gilead Sciences, Inc., Foster City, California, USA
References
1. Stribild [package insert]. Foster City, CA: Gilead Sciences, Inc., 9/2016; 2. Lepist I, et al. ICAAC 2011, poster A1-1724; 3. German P, et al. J Acquir Immune Defic Syndr 2012;61:32-40; 4. Ramanathan S, et al. CROI 2013, poster 524; 5. Atripla [package
insert]. Foster City, CA: Gilead Sciences, Inc., 4/2017; 6. Klein CE, et al. J Clin Pharmacol 2008;48:553-62; 7. Truvada [package insert]. Foster City, CA: Gilead Sciences, Inc., 4/2017.
|
| |
|
|
|
|
|
